Robert A. Scott

Board Director

Director

US·SEC (Form 4)

Windtree Therapeutics Inc

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 25 Aug 2023 for Windtree Therapeutics INC. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Robert A. Scott: trading record in brief

This profile gathers the share dealings of Robert A. Scott in Windtree Therapeutics Inc, where the filings describe the role as board member. We count 2 filings; the first trade dates from 7 June 2022 and the latest from 23 August 2023.

Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The latest filing, published on 25 August 2023, reports a share grant in Windtree Therapeutics Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.